The use of Genito Urinary System and Sex Hormones in the Netherlands is forecasted to remain relatively stable from 2024 to 2028, with values between 52.3 and 52.5 units (Defined Daily Dosage) per thousand persons per day. In 2023, the actual usage stood at the same level, suggesting no significant growth or decline. Year-on-year variations indicate a slightly decreasing trend, with a drop of 0.19% in 2026 and 0.20% in 2027. Over the past two years, slight decreases in usage can be observed, but the compound annual growth rate (CAGR) for the period is negligible.
Future trends to watch for include potential changes in population demographics, healthcare policies, and advancements in medical treatments which could influence this stable trend. Increasing awareness and use of alternative medicines or changes in prescription habits may also impact future usage rates.
